Cargando…

The Lifetime Cost Estimation of Human Papillomavirus-related Diseases in China: A Modeling Study

OBJECTIVES: To estimate the lifetime treatment costs of patients with human papillomavirus (HPV) infection-related diseases in China and to provide cost estimates for the economic evaluation of HPV intervention strategies. METHODS: We extracted real-world hospital data from 2012 to 2019 and screened...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ding, Wenpei, Ma, Yue, Ma, Chao, Malone, Daniel C, Ma, Aixia, Tang, Wenxi, Si, Lei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sciendo 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8629412/ https://www.ncbi.nlm.nih.gov/pubmed/34900631 http://dx.doi.org/10.2478/jtim-2021-0039

Ejemplares similares

Value of Perampanel as Adjunctive Treatment for Partial-Onset Seizures in Epilepsy: Cost-Effectiveness and Budget Impact Analysis
por: Zhang, Donger, et al.
Publicado: (2021)

Value of Active Warming Devices for Intraoperative Hypothermia Prevention—A Meta-Analysis and Cost-Benefit Analysis
por: Xu, He, et al.
Publicado: (2021)

Estimated Cost of Circulating Tumor DNA for Posttreatment Surveillance of Human Papillomavirus–Associated Oropharyngeal Cancer
por: Kowalchuk, Roman O., et al.
Publicado: (2022)

Estimating lifetime healthcare costs with morbidity data
por: Carreras, Marc, et al.
Publicado: (2013)

A parameter estimation method for fluorescence lifetime data
por: Sewell, Daniel, et al.
Publicado: (2015)

Safety of intraoperative hypothermia for patients: meta-analyses of randomized controlled trials and observational studies
por: Xu, He, et al.
Publicado: (2020)

Estimating the direct effect of human papillomavirus vaccination on the lifetime risk of screen‐detected cervical precancer
por: Inturrisi, Federica, et al.
Publicado: (2020)

Estimating the cost-effectiveness threshold of advanced non-small cell lung cancer in China using mean opportunity cost and contingent valuation method
por: Peng, Qian, et al.
Publicado: (2023)

The cost-effectiveness analysis of serplulimab versus regorafenib for treating previously treated unresectable or metastatic microsatellite instability-high or deficient mismatch repair colorectal cancer in China
por: Ma, Yue, et al.
Publicado: (2023)

Is the Scope of Costs Considered in Budget Impact Analyses for Anticancer Drugs Rational? A Systematic Review and Comparative Study
por: Ma, Yue, et al.
Publicado: (2021)

Vaccinating women previously treated for human papillomavirus-related cervical precancerous lesions is highly cost-effective in China
por: Zou, Maosheng, et al.
Publicado: (2023)

Improving satellite-based PM(2.5) estimates in China using Gaussian processes modeling in a Bayesian hierarchical setting
por: Yu, Wenxi, et al.
Publicado: (2017)

Effectiveness and Efficiency of Non-drug Therapy Among Community-Dwelling Adults With Hypertension in China: A Protocol for Network Meta-Analysis and Cost-Effectiveness Analysis
por: Shao, Taihang, et al.
Publicado: (2021)

Characteristics of women infected with human papillomavirus in a tertiary hospital in Beijing China, 2014–2018
por: Ma, Liang, et al.
Publicado: (2019)

Genotype distribution and the relative risk factors for human papillomavirus in Urumqi, China
por: CHEN, ZHIFANG, et al.
Publicado: (2013)

The healthcare costs of treating human papillomavirus-related cancers in Norway
por: Hylin, Hannah, et al.
Publicado: (2019)

Empirically Estimated Electron Lifetimes in the Earth's Radiation Belts: Comparison With Theory
por: Claudepierre, S. G., et al.
Publicado: (2020)

Estimation of Life-Year Loss and Lifetime Costs for Different Stages of Colon Adenocarcinoma in Taiwan
por: Chen, Po-Chuan, et al.
Publicado: (2015)

Establishing a method to estimate the effect of antimyopia management options on lifetime cost of myopia
por: Fricke, Tim R, et al.
Publicado: (2023)

The prevalence and genotype distribution of human papillomavirus among women in Guangxi, southern China
por: Wei, Liuting, et al.
Publicado: (2022)

Genotype distribution and prevalence of human papillomavirus among women with cervical cytological abnormalities in Xinjiang, China
por: Wang, Jing, et al.
Publicado: (2019)

Cost-effectiveness of human papillomavirus vaccine in China: a systematic review of modelling studies
por: Shi, Wenchuan, et al.
Publicado: (2021)

Cost-Effectiveness Analysis of Human Papillomavirus Vaccination in Adolescent Girls in Taiwan
por: Tang, Chao-Hsiun, et al.
Publicado: (2019)

The prevalence of human papillomavirus among women in northern Guangdong Province of China
por: Huang, Wenbo, et al.
Publicado: (2022)

Willingness to human papillomavirus (HPV) vaccination and influencing factors among male and female university students in China
por: Dai, Zhenwei, et al.
Publicado: (2021)

Cost-Utility Analysis of the Integrated Care Models for the Management of Hypertension Patients: A Quasi-Experiment in Southwest Rural China
por: Ke, Xiatong, et al.
Publicado: (2021)

Empirically Estimated Electron Lifetimes in the Earth's Radiation Belts: Van Allen Probe Observations
por: Claudepierre, S. G., et al.
Publicado: (2020)

Cost-effectiveness analysis of camrelizumab plus chemotherapy as first-line treatment for advanced squamous NSCLC in China
por: Shao, Taihang, et al.
Publicado: (2022)

Lifetime Estimation for Multi-Phase Deteriorating Process with Random Abrupt Jumps †
por: Zhang, Jianxun, et al.
Publicado: (2019)

Status of Human Papillomavirus Infection in the Ethnic Population in Yunnan Province, China
por: Baloch, Zulqarnain, et al.
Publicado: (2015)

Estimation of the costs of cervical cancer screening, diagnosis and treatment in rural Shanxi Province, China: a micro-costing study
por: Shi, Ju-Fang, et al.
Publicado: (2012)

Incidence, Mortality Features and Lifetime Risk Estimation of Digestive Tract Cancers in an Urban District of Shanghai, China
por: Bi, Jing-Hao, et al.
Publicado: (2022)

Cost analysis of Human Papillomavirus-related cervical diseases and genital warts in Swaziland
por: Ginindza, Themba G., et al.
Publicado: (2017)

Estimated annual prevalence, medical service utilization and direct costs of lung cancer in urban China
por: Zhu, Dawei, et al.
Publicado: (2021)

Effect of vaccination age on cost-effectiveness of human papillomavirus vaccination against cervical cancer in China
por: Liu, Yi-Jun, et al.
Publicado: (2016)

Cost-effectiveness of human papillomavirus vaccination in Germany
por: Damm, Oliver, et al.
Publicado: (2017)

Costs of delivering human papillomavirus vaccination in Tanzania
por: Struckmann, V, et al.
Publicado: (2022)

Cost-Effectiveness Analysis of Five Systemic Treatments for Unresectable Hepatocellular Carcinoma in China: An Economic Evaluation Based on Network Meta-Analysis
por: Zhao, Mingye, et al.
Publicado: (2022)

Estimation of the cost-effective threshold of a quality-adjusted life year in China based on the value of statistical life
por: Cai, Dan, et al.
Publicado: (2021)

Trial-Based Cost-Utility Analysis of Icotinib versus Gefitinib as Second-Line Therapy for Advanced Non-Small Cell Lung Cancer in China
por: Zhang, Chunxiang, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_1tr3gjv1mdf0l755tb0jmn1va0